Stem cell therapy is emerging as a potential treatment for different conditions in endocrinology, including diabetes and ...
In the fourth quarter of 2024, BB Biotech shares posted a total return of -2.7% in CHF and -3.5% in EUR. NAV performance improved, rising by 2.7% in CHF and 2.8% in EUR, though it declined by 4.3% in ...
The group of Prof. Charna Dibner contributes to translational chronobiology and chronomedicine by developing two major lines of research: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback